ImmunoPrecise Antibodies
IPA
$1.00
Share price
0.00%
Change (1 day)
-68.25%
Change (1 year)
Categories
ImmunoPrecise Antibodies (IPA) - Total liabilities
Total liabilities on the balance sheet as of January 2024 : $21.54 M
According to ImmunoPrecise Antibodies's latest financial reports the company's total liabilities are $21.54 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
ImmunoPrecise Antibodies - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-04-30 | $14.75 M | 3.3% |
| 2022-04-30 | $14.28 M | 74.77% |
| 2021-04-30 | $8.17 M | -6.86% |
| 2020-04-30 | $8.77 M | 13.61% |
| 2019-04-30 | $7.72 M | -16.46% |
| 2018-04-30 | $9.24 M | 1407.23% |
| 2017-04-30 | $0.61 M | 62.98% |
| 2016-04-30 | $0.37 M | |
| 2015-12-31 | $0.18 M | -15.99% |
| 2014-12-31 | $0.21 M | -23.04% |
| 2013-12-31 | $0.28 M | 6.73% |
| 2012-12-31 | $0.26 M | 27.97% |
| 2011-12-31 | $0.2 M | 89.33% |
| 2010-12-31 | $0.11 M | 18.53% |
| 2009-12-31 | $0.09 M | -25.02% |
| 2008-12-31 | $0.12 M | 230.38% |
| 2007-12-31 | $0.03 M | -89.43% |
| 2006-12-31 | $0.35 M | 198.61% |
| 2005-12-31 | $0.11 M | 202.93% |
| 2004-12-31 | $0.03 M | 2.07% |
| 2003-12-31 | $0.03 M | 78.5% |
| 2002-12-31 | $0.02 M | -84.27% |
| 2001-12-31 | $0.13 M |